FRESCO-2

Home Tag

Copia de Copia de Copia de Banner web VHIO (4)

VHIO-led FRESCO-2 phase 3 trial leads to approval from EMA for the first novel targeted therapy for metastatic colorectal cancer in over a decade

Announced by the European Medicines Agency (EMA) last month, June 21, the highly selective and potent VEGFR inhibitor fruquintinib has…